Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Tubersol Market Size Forecast: How Big Could The Market Get By 2030?
Historically, the growth witnessed was primarily driven by a sustained dependence on tuberculin skin testing and the implementation of extensive public health TB screening programs. The accessibility of PPD diagnostic solutions also played a role, alongside global TB surveillance initiatives and the successful integration of TST into standard healthcare practices.
The projected expansion throughout the forecast period stems from broader screening efforts within high-risk populations, an escalating governmental focus on eliminating tuberculosis, improved access to diagnostic testing, the widening scope of occupational health screenings, and increased funding directed towards infectious disease control. Significant trends for the forecast duration involve the growing adoption of tuberculin skin testing programs, a heightened emphasis on early tuberculosis diagnosis, the expansion of public health screening initiatives, an increasing demand for latent tuberculosis detection, and enhanced standardization of diagnostic protocols.
Get A Free Sample Report With In-Depth Market Insights:
Tubersol Market Growth Momentum: What Factors Are Shaping Demand?
The increasing occurrence of tuberculosis is projected to stimulate the growth of the tubersol market. Tuberculosis (TB) is a contagious bacterial infection stemming from mycobacterium tuberculosis, which primarily targets the lungs but can also affect other body parts. The rising incidence of tuberculosis can be attributed to several factors including co-infection with HIV/AIDS, drug resistance, global movements and migration, inadequate nutrition, congested living environments, limited access to medical services, societal stigma, and poor ventilation. Tubersol is employed in the tuberculin skin test (TST) to aid in detecting latent tuberculosis infections by eliciting an immune reaction to the purified protein derivative of the TB bacteria. For instance, in March 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, signifying an increase of 1,295 cases. Consequently, the escalating prevalence of tuberculosis is a driving force for the tubersol market’s expansion.
Tubersol Market Segment Landscape And Growth Outlook
The tubersol market covered in this report is segmented –
1) By Clinical Indication: Tuberculosis Screening, Diagnosis Of Active Tuberculosis, Diagnosis Of Latent Tuberculosis, Other Respiratory Diseases
2) By Formulation: Single-Dose Vials, Multi-Dose Vials
3) By Distribution Channel: Hospital And Clinics, Retail And Specialty Pharmacies, Online Sales
4) By End User: Adult, Geriatric, Pediatric
Tubersol Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the tubersol market are Sanofi S.A.
View The Full Tubersol Market Report:
Tubersol Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the tubersol market in 2025. The regions covered in the tubersol market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
